Market Research Report
Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model
|Published by||GlobalData||Product code||398053|
Delivery time: 1-2 business days
|Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model|
|Published: May 15, 2019||Content info:||
Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
Hepatitis C is a viral infection caused by Hepatitis C virus (HCV). Hepatitis C virus is a blood borne virus that causes liver disease and can cause acute and chronic hepatitis. Infection may be caused through injection drug use, transfusion of unscreened blood products, unsafe injection practices, sexual contact and from infected mother to her baby. Diagnosis of HCV infection can be done by screening for anti-HCV antibodies along with a serological test to confirm the viral infection. Nucleic Acid Test for HCV Ribonucleic Acid (RNA) is often performed in cases to confirm chronic infection.
The World Health Organization estimates that 71 million people are living with chronic hepatitis C infection globally. Disease incidence and prevalence are not the only factors influencing the Hepatitis C Tests market. Sales of these devices are also heavily impacted by fluctuations in the number of pregnant women, semen donations, whole blood donations, and source plasma donations.
The predominant devices used for Hepatitis C detection are enzyme immunoassay (EIA) tests, owing to their high specificity and sensitivity as well as their ability to be adapted for high-throughput testing. EIA Hepatitis C devices are used for disease diagnosis as well as screening of whole blood, source plasma, and sperm donations as well as for pregnant women screening. Nucleic Acid Amplification (NAAT) tests are sometimes used as confirmatory tests for samples that have already tested positive for HCV through EIA. NAAT are also used for serial monitoring of Hepatitis C patients, to aid in management of the disease and to inform treatment strategies i.e. with anti-retroviral agents.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Bio-Rad Laboratories Inc, Hologic Inc, Ortho-Clinical Diagnostics Inc, Bio Manguinhos and Fiocruz, Grifols, S.A, F. Hoffmann-La Roche Ltd (Roche Diagnostics International Ltd), Siemens Healthineers AG, Qiagen NV, bioMerieux SA, DiaSorin S.p.A., United States Biological, SeraCare Life Sciences, Inc., ThermoFisher Scientific and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -